RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.43
−8.59%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-16.1%
Return on equity
-11.6%
Return on assets
-17.1%
Return on invested capital
0.00x
Asset turnover
-$5.92T
Cash from operations
$1.6M
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026